Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation

Biochimie

Volumn 82, Issue 1, 2000, Pages 51-58

  Guillouf, Christel ^a   Vit, Jean Philippe ^a   Rosselli, Filippo ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA; DNA POLYMERASE; MITOMYCIN C;

APOPTOSIS; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; FANCONI ANEMIA; GAMMA RADIATION; GENE ACTIVITY; HUMAN; HUMAN CELL;

EID: 0033969865     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(00)00359-X     Document Type: Article

References (67)

1. Liu J.M., Buchwald M., Walsh C.E., Young N.S. Fanconi anemia and novel strategies for therapy. Blood. 84:1994;3995-4007.
2. Auerbach A.D., Allen R.G. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the international Fanconi anemia registry. Cancer Genet. Cytogenet. 51:1991;1-12.
3. Weksberg R., Buchwald M., Sargent P., Thompson M.W., Siminovitch L. Specific cellular defects in patients with Fanconi anemia. J. Cell Physiol. 101:1979;311-324.
4. Dutrillaux B., Aurias A., Dutrillaux A.M., Buriot D., Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum. Genet. 62:1992;327-332.
5. Gluckman E., Devergie A., Dutreix J. Radiosensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplatation. Br. J. Haematol. 54:1983;431-440.
6. Joenje H., Arwert F., Eriksson A.W., de Koning H., Oostra A.B. Oxygen dependence of chromosomal aberrations in Fanconi's anemia. Nature. 290:1981;142-143.
7. Hoehn H., Kubbies M., Schindler D., Poot M., Rabinovitch P.S. BrdU-Hoechst flow cytometry links the cell kinetic defect of Fanconi anemia to oxygen hypersensitivity. Schroeder-Kurth T.M, Auerbach A.D, Obe G. Fanconi anemia. Clinical, cytogenetic and experimental aspects. 1989;161-179 Springer-Verlag, Berlin.
8. Schultz J.C., Shahidi N.T. Tumor necrosis factor α overproduction in Fanconi's anemia. Am. J. Hematol. 42:1993;196-201.
9. Rosselli F., Sanceau J., Gluckman E., Wietzerbin J., Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II: In vitro and in vivo overproduction of tumor necrosis factor α Blood. 83:1994;1216-1225.
10. Escarceller M., Buchwald M., Singleton B.K., Jeggo P.A., Jackson S.P., Moustacchi E., Papadopoulo D. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J. Mol. Biol. 279:1998;375-385.
11. Clarke A.A., Marsh J.C.W., Gordon E.C., Rutherford T.R. Molecular genetic and Fanconi anemia: new insights into old problems. Br J. Haemat. 103:1998;287-296.
12. Strathdee C.A., Duncan A.M.W., Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nature Genet. 1:1992;196-198.
13. Joenje H., Lo Ten Foe J.R., Oostra A.B., Van Berkel C.G.M., Rooimans M.A., Schroeder-Kurth T., Wegner R.D., Gille J.J.P., Buchwald M., Arwert F. Classification of Fanconi anemia patients by complementation analysis: Evidence for a fifth genetic subtype. Blood. 86:1995;2156-2160.
14. Joenje H., Oostra A.B., Wijker M., di Suma F.M., Van Berkel C.G.M., Rooimans M.A., Ebell W., van Weel M., Pronk J.C., Buchwald M., Arwert F. Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet. 61:1997;940-944.
15. Strathdee C.A., Gavish H., Shannon W.R., Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 356:1992;763-767.
16. Lo Ten Foe J.R., Rooimans M.A., Bosnoyab-Collins L., Allon N., Wijker M., Parker L., Lightfoot J., Carreau M., Callen D.F., Savoia A., Chen N.C., Van Berkel C.G.M., Strunk M.H.P., Gille J.J.P., Pals G., Kruyt F.A.E., Pronk J.C., Arwert F., Buchwald M., Joenje H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genet. 14:1996;320-323.
17. Positional cloning of the Fanconi anaemia group A gene. Nature Genet. 14:1996;324-328.
18. de Winter J.P., Waisfisz Q., Rooimans M.A., van Berkel C.G., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J.C., Arwert F., Hoehn H., Digweed M., Buchwald M., Joenje H. The Fanconi anemia group G gene FANCG is identical with XRCC9. Nature Genet. 20:1999;281-283.
19. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc. Natl. Acad. Sci. USA. 91:1994;7975-7979.
20. Hoatlin M.E., Christianson T.A., Keeble W.W., Hammond A.T., Zhi Y., Heinrich M., Tower P.A., Bagby G.C. The Fanconi anemia groupC gene product is localised both the nucleus and cytoplasm of human cells. Blood. 91:1998;1418-1425.
21. Kupfer G.M., Naf D., Suliman A., Pulsipher M., D'Andrea A.D. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nature Genet. 17:1997;487-490.
22. Kruyt F., Youssoufian H. The Fanconi anemia FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity. Blood. 92:1998;2229-2236.
23. Näf D., Kupfer G.M., Suliman A., Lambert K., D'Andrea A.D. Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol. Cell Biol. 18:1998;5952-5960.
24. Garcia-Higuera I., Kuang Y., Naf D., Wasik J., D'Andrea A.D. Fanconi anemia proteins FANCA, FANCC and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19:1999;4866-4873.
25. Kruyt F.A., Hoshino T., Liu J.M., Joseph P., Jaiswal A.K., Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood. 92:1998;3050-3056.
26. Maciejewsk I.J., Seller C., Anderson S., Young N. Fas antigen expression on CD34+ human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood. 85:1995;3183-3187.
27. Ridet A., Guillouf C., Duchaud E., Cundari E., Fiore M., Moustacchi E., Rosselli F. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 57:1997;1722-1730.
28. Rathburn R., Faulkner G., Ostroski M., Christianson T., Hughes G., Jones G., Cahn R., Maziarz R., Royle G., Keeble W., Heinrich M., Grompe M., Tower P., Bagby G. Inactivation of the Fanconi anemia group C gene augments Interferon-γ-induced apoptotic responses in hematopoietic cells. Blood. 90:1997;974-985.
29. Haneline L.S., Broxmeyer H.E., Cooper S., Hangoc G., Carreau M., Buchwald M., Clapp D.W. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood. 91:1998;4092-4098.
30. Otsuki T., Nagakura S., Wang J., Bloom M., Grompe M., Liu J.M. Tumor necrosis factor a and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice. J. Cell Physiol. 179:1999;79-86.
31. Cumming R.C., Liu J.M., Youssoufian H., Buchwald M. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood. 88:1996;4558-4567.
32. Guillouf C., Wang T.S., Liu J., Walsh C.E., Poirier G.G., Moustacchi E., Rosselli F. Fanconi anemia C acts at a switch between apoptosis and necrosis in mytomicin C- induced cell death. Exp. Cell. Res. 246:1999;384-394.
33. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., Poirier G.G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
34. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347.
35. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
36. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The relases of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
37. Clarke A.A., Philpott N.J., Gordon-Smith E.C., Rutherford T.R. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br. J. Haematol. 96:1997;240-247.
38. Yamashita T., Wu N., Kupfer G., Corless C., Joenje H., Grompe M., D'Andrea A.D. Clinical variability of Fanconi anemia (type C) results from expression of an amino acid terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood. 87:1996;4424-4432.
39. Parker L., DosSantos C., Buchwald M. The Δ327 mutation in the Fanconi anemia group C gene generates a novel transcript lacking the first two coding exons. Hum. Mut. (Suppl. 1):1998;S275-S277.
40. Henkart P.A. ICE family proteases: mediators of all apoptotic cell death? Immunity. 4:1996;195-201.
41. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirements for caspase-9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
42. Woo M. Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:1998;806-819.
43. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
44. Vaux D.L., Wilhelm S., Häcker G. Requirements for proteolysis during apoptosis. Mol. Cell. Biol. 17:1997;6502-6507.
45. Nicholson D.W., Thornberry N.A. Caspases: killer proteases. TIBS. 22:1997;299-306.
46. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell. 81:1995;801-809.
47. Datta R., Kojima H., Banach D., Bump N.J., Talanian R.V., Alnemri E.S., Weichselbaum R.R., Wong W.W., Kufe D.W. Activation of a CrmA-insensitive, p35-sensitive pathway in IR-induced apoptosis. J. Biol. Chem. 272:1997;1965-1969.
48. Fernandes-Alnemri T., Litwack G., Alnemri E.S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 269:1994;30761-30764.
49. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.T., Yu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
50. Ishida R., Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA cross-linking and alkylating agents. Cancer Res. 42:1982;4000-4006.
51. Nagata S. Apoptosis by death factors. Cell. 88:1997;355-365.
52. Li N. Cytochrome c and ATP-dependent formation of Apaf1/caspase 9 complex initiates α apoptotic protease cascade. Cell. 91:1997;479-489.
53. Zou H., Henkel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochromec-dependent activation of caspase-3. Cell. 90:1997;405-413.
54. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
55. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
56. Fulda S., Scaffidi C., Pietsch T., Krammer P.H., Peter M.E., Debatin K.M. Activation of the CD95 (APO1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells. Cell Death Diff. 5:1998;884-893.
57. Eischen C.M., Kottke T.J., Martins L.M., Basi G.S., Tung J.S., Earnshaw W.C., Leibst N., Kaufmann S.H. Comparison of apoptosis in wild-type and resistant cells: chemotherapy-induced apoptosis is not dependent of Fas ligand interactions. Blood. 90:1997;935-943.
58. Boesen-de-Cock J.G.R., Tüpper A.D., de Vries E., van Blitterswijk W.J., Borst J. Common regulation of apoptosis signaling induced by CD-95 and the DNA-damaging stimuli etoposide and γ-radiation downstream from caspase-8 activation. J. Biol. Chem. 274:1999;14255-14261.
59. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1995;1675-1687.
60. Kruyt F.A.E., Dijkmans L.M., Van der Beng T.K., Joenje H. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood. 87:1996;938-948.
61. Marathi U.K., Howell S.R., Ashmun R.A., Brent T.P. The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. Blood. 6:1996;2298-2305.
62. Kockx M.M., Muhring J., Knaapen M.W., de Meyer G.R. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am. J. Pathol. 152:1998;885-888.
63. Lyman S.D., Seaberg M., Hanna R., Zappone J., Brasel K., Abkowitz J.L., Prchal J.T., Schultz J.C., Shahidi N.T. Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia. Blood. 86:1995;4091-4096.
64. Lisovsky M., Estrov Z., Zhang X., Consoli U., Sanchez-Williams G., Snell V., Munker R., Goodacre A., Savchenko V., Andreef M. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood. 88:1996;3987-3997.
65. Veiby O.P., Jacobsen F.W., Cui L., Lyman S.D., Jacobsen S.E.W. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta. J. Immunol. 157:1996;2953-2960.
66. Gratwohl A., Baldomero J.H., Roth J., Tichelli A., Nissen C., Lyman S.D., Wodnar-Filipowicz A. FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood. 92:1998;765-769.
67. Hudak S., Leach M.W., Xu Y., Menon S., Rennick D. Radioprotective effects of flk2/flt3 ligand. Exp. Hematol. 26:1998;515-522.